Symbols

PYXS

Pyxis Oncology·NASDAQ

--(--)

PYXS Profile

Pyxis Oncology, Inc.

A diversified oncology company focused on developing therapeutics to target difficult-to-treat cancers

Industry

Pharmaceutical

Established Date

06/11/2018

Listing Date

10/08/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.pyxisoncology.com

Security Type

Common stock

Office address

321 Harrison Avenue Boston Massachusetts 02118

Business

Introduction

Pyxis Oncology, Inc., was incorporated in Delaware on June 11, 2018. The company is a clinical-stage oncology company advancing a development strategy focused on addressing the unmet medical needs of patients with solid tumors, with an immediate focus on head and neck squamous cell carcinoma (HNSCC).